{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:37:29Z","timestamp":1792798649266,"version":"4.5.0"},"reference-count":60,"publisher":"BMJ","issue":"2","funder":[{"name":"Mayo Clinic Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, MN.","id":[{"id":"https:\/\/ror.org\/02qp3tb03","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN.","id":[{"id":"https:\/\/ror.org\/02qp3tb03","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Evid Based Mental Health"],"accepted":{"date-parts":[[2020,11,30]]},"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Multiple sclerosis (MS) is a chronic disabling, demyelinating disease of the central nervous system and is often associated with psychiatric comorbidities. Some studies suggest increased prevalence of bipolar disorder (BD) in MS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To conduct a systematic review and meta-analysis assessing the prevalence of BD in adults with MS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We registered this review with PROSPERO and searched electronic databases (Ovid MEDLINE, Central, Embase, PsycINFO and Scopus) for eligible studies from earliest inception to October 2020. Prevalence data of BD in adult patients with MS were extracted. Meta-analysis was conducted using random-effects model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>Of the 802 articles that were screened, 23 studies enrolling a total of 68 796 patients were included in the systematic review and meta-analysis. The pooled prevalence rate of BD in patients with MS was 2.95% (95% CI 2.12% to 4.09%) with higher prevalence in the Americas versus Europe. The lifetime prevalence of BD was 8.4% in patients with MS. Subgroup analysis showed a higher prevalence of BD in MS in females (7.03%) than in males (5.64%), which did not reach statistical significance (p=0.53).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This meta-analysis suggests a high lifetime prevalence of BD in patients with MS. Patients with MS should be routinely screened for BD. Further assessment of bipolar comorbidity in MS through prospective studies may help in developing effective management strategies and may improve treatment outcomes in patients with MS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/ebmental-2020-300207","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T19:02:04Z","timestamp":1608145324000},"page":"88-94","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":31,"title":["Prevalence of bipolar disorder in multiple sclerosis: a systematic review and meta-analysis"],"prefix":"10.1136","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1576-9344","authenticated-orcid":false,"given":"Boney","family":"Joseph","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiswarya L","family":"Nandakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed T","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neethu","family":"Gopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Hassan","family":"Murad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A","family":"Frye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W Oliver","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7062-8192","authenticated-orcid":false,"given":"Balwinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,12,16]]},"reference":[{"key":"2024052111025996000_24.2.88.1","first-page":"753","article-title":"Management of multiple sclerosis symptoms and comorbidities","volume":"25","author":"Tobin","year":"2019","journal-title":"Continuum"},{"key":"2024052111025996000_24.2.88.2","unstructured":"Multiple Sclerosis International Federation . London. atlas of MS 2013: mapping multiple sclerosis around the world. Available: http:\/\/www.msif.org\/about-ms\/publications-and-resources\/2013"},{"key":"2024052111025996000_24.2.88.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30443-5"},{"key":"2024052111025996000_24.2.88.4","doi-asserted-by":"publisher","DOI":"10.1159\/000342779"},{"key":"2024052111025996000_24.2.88.5","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-13-128"},{"key":"2024052111025996000_24.2.88.6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/7854_2015_370","article-title":"Sex-Based differences in multiple sclerosis (MS): Part II: rising incidence of multiple sclerosis in women and the vulnerability of men to progression of this disease","volume":"26","author":"Dunn","year":"2015","journal-title":"Curr Top Behav Neurosci"},{"key":"2024052111025996000_24.2.88.7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the global burden of disease study 2016","volume":"18","year":"2019","journal-title":"Lancet Neurol"},{"key":"2024052111025996000_24.2.88.8","doi-asserted-by":"publisher","DOI":"10.1177\/1352458512451510"},{"key":"2024052111025996000_24.2.88.9","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514564491"},{"key":"2024052111025996000_24.2.88.10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/PROM.S148387","article-title":"Comorbidity in US patients with multiple sclerosis","volume":"9","author":"Edwards","year":"2018","journal-title":"Patient Relat Outcome Meas"},{"key":"2024052111025996000_24.2.88.11","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2016-315367"},{"key":"2024052111025996000_24.2.88.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00241-X"},{"key":"2024052111025996000_24.2.88.13","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.167"},{"key":"2024052111025996000_24.2.88.14","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.64.5.543"},{"key":"2024052111025996000_24.2.88.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0193-953X(03)00036-4"},{"key":"2024052111025996000_24.2.88.16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4103\/0019-5545.161488","article-title":"Bipolar disorder in women","volume":"57","author":"Parial","year":"2015","journal-title":"Indian J Psychiatry"},{"key":"2024052111025996000_24.2.88.17","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0278-5846(03)00116-7","article-title":"Familial bipolar disorder and multiple sclerosis: a three-generation HLA family study","volume":"27","author":"Bozikas","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2024052111025996000_24.2.88.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2011.11.014"},{"key":"2024052111025996000_24.2.88.19","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.11"},{"key":"2024052111025996000_24.2.88.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2015.08.001"},{"key":"2024052111025996000_24.2.88.21","doi-asserted-by":"publisher","DOI":"10.1080\/09638280902738664"},{"key":"2024052111025996000_24.2.88.22","doi-asserted-by":"publisher","DOI":"10.1191\/1352458504ms1087oa"},{"key":"2024052111025996000_24.2.88.23","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.22.1.63"},{"key":"2024052111025996000_24.2.88.24","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(00)00298-6"},{"key":"2024052111025996000_24.2.88.25","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-005-0468-8"},{"key":"2024052111025996000_24.2.88.26","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.msard.2017.10.001","article-title":"The impact of treatment adherence on clinical and economic outcomes in multiple sclerosis: real world evidence from Alberta, Canada","volume":"18","author":"Gerber","year":"2017","journal-title":"Mult Scler Relat Disord"},{"key":"2024052111025996000_24.2.88.27","doi-asserted-by":"publisher","DOI":"10.1159\/000311013"},{"key":"2024052111025996000_24.2.88.28","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1987.00520160018007"},{"key":"2024052111025996000_24.2.88.29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1176\/appi.neuropsych.15120403","article-title":"The prevalence of bipolar disorders and association with quality of life in a cohort of patients with multiple sclerosis","volume":"29","author":"Jun-O'Connell","year":"2017","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2024052111025996000_24.2.88.30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.18621\/eurj.382894","article-title":"The relationship between psychopathology, psychosocial adjustment, social support and quality of life in multiple sclerosis","volume":"5","author":"Kotan","year":"2019","journal-title":"Eur Res J"},{"key":"2024052111025996000_24.2.88.31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2019.10.1165","article-title":"Prevalence of comorbidities in relapsing-remitting and secondary progressive multiple sclerosis","volume":"405","author":"Kurnaz","year":"2019","journal-title":"J Neurol Sci"},{"key":"2024052111025996000_24.2.88.32","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1212\/WNL.0000000000004686","article-title":"Assessing association of comorbidities with treatment choice and persistence in MS: a real-life multicenter study","volume":"89","author":"Laroni","year":"2017","journal-title":"Neurology"},{"key":"2024052111025996000_24.2.88.33","doi-asserted-by":"publisher","DOI":"10.1177\/1352458510365157"},{"key":"2024052111025996000_24.2.88.34","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s10072-015-2220-3","article-title":"Progressive multiple sclerosis and mood disorders","volume":"36","author":"Lorefice","year":"2015","journal-title":"Neurol Sci"},{"key":"2024052111025996000_24.2.88.35","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002174"},{"key":"2024052111025996000_24.2.88.36","doi-asserted-by":"publisher","DOI":"10.1177\/1352458508099477"},{"key":"2024052111025996000_24.2.88.37","first-page":"169","article-title":"Excess of neurological and psychiatric comorbidity in multiple sclerosis patients as compared to the general population in Catalonia, Spain","volume":"23","author":"Passarell","year":"2017","journal-title":"Mult Scler"},{"key":"2024052111025996000_24.2.88.38","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700005602"},{"key":"2024052111025996000_24.2.88.39","first-page":"55","article-title":"Personality disorders in pateints with multiple sclerosis: prevalence and association with depressive and anxiety disorders and clinical features","volume":"21","author":"Uca","year":"2016","journal-title":"Neurology Asia"},{"key":"2024052111025996000_24.2.88.40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/13651500701330825","article-title":"Mood and anxiety disorders in patients with multiple sclerosis","volume":"12","author":"Uguz","year":"2008","journal-title":"Int J Psychiatry Clin Pract"},{"key":"2024052111025996000_24.2.88.41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jad.2017.10.027","article-title":"Systemic autoimmune diseases are associated with an increased risk of bipolar disorder: a nationwide population-based cohort study","volume":"227","author":"Wang","year":"2018","journal-title":"J Affect Disord"},{"key":"2024052111025996000_24.2.88.42","first-page":"429","article-title":"Psychological characterization of a cohort of multiple sclerosis patients in Chile","volume":"25","author":"Weaver","year":"2019","journal-title":"Mult Scler"},{"key":"2024052111025996000_24.2.88.43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104165"},{"key":"2024052111025996000_24.2.88.44","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2011.12"},{"key":"2024052111025996000_24.2.88.45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jad.2014.02.006","article-title":"More pernicious course of bipolar disorder in the United States than in many European countries: implications for policy and treatment","volume":"160","author":"Post","year":"2014","journal-title":"J Affect Disord"},{"key":"2024052111025996000_24.2.88.46","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1590\/1516-4446-2012-1693","article-title":"Bipolar disorder prevalence: a systematic review and meta-analysis of the literature","volume":"37","author":"Clemente","year":"2015","journal-title":"Braz J Psychiatry"},{"key":"2024052111025996000_24.2.88.47","doi-asserted-by":"publisher","DOI":"10.1177\/1352458512447527"},{"key":"2024052111025996000_24.2.88.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2013.05.034"},{"key":"2024052111025996000_24.2.88.49","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2014.13081008"},{"key":"2024052111025996000_24.2.88.50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1100648"},{"key":"2024052111025996000_24.2.88.51","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/mp.2017.73","article-title":"Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the enigma bipolar disorder Working group","volume":"23","author":"Hibar","year":"2018","journal-title":"Mol Psychiatry"},{"key":"2024052111025996000_24.2.88.52","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/brainsci7110144","article-title":"Bipolar disorder and immune dysfunction: epidemiological findings, proposed pathophysiology and clinical implications","volume":"7","author":"Rosenblat","year":"2017","journal-title":"Brain Sci"},{"key":"2024052111025996000_24.2.88.53","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2013.195"},{"key":"2024052111025996000_24.2.88.54","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/acps.12912","article-title":"HLA genetics in bipolar disorder","volume":"138","author":"Tamouza","year":"2018","journal-title":"Acta Psychiatr Scand"},{"key":"2024052111025996000_24.2.88.55","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000333252.78173.5f"},{"key":"2024052111025996000_24.2.88.56","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.genhosppsych.2018.06.001","article-title":"Psychiatric comorbidity increases mortality in immune-mediated inflammatory diseases","volume":"53","author":"Marrie","year":"2018","journal-title":"Gen Hosp Psychiatry"},{"key":"2024052111025996000_24.2.88.57","unstructured":"Bipolar and Related Disorders . Diagnostic and statistical manual of mental disorders. 5th edn, 2013."},{"key":"2024052111025996000_24.2.88.58","first-page":"57","article-title":"Misdiagnosis of bipolar disorder","volume":"3","author":"Singh","year":"2006","journal-title":"Psychiatry"},{"key":"2024052111025996000_24.2.88.59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/297087","article-title":"Overdiagnosis of bipolar disorder: a critical analysis of the literature","volume":"2013","author":"Ghouse","year":"2013","journal-title":"ScientificWorldJournal"},{"key":"2024052111025996000_24.2.88.60","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(99)00161-4"}],"container-title":["Evidence Based Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ebmental-2020-300207","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T14:36:56Z","timestamp":1716302216000},"score":1,"resource":{"primary":{"URL":"https:\/\/mentalhealth.bmj.com\/lookup\/doi\/10.1136\/ebmental-2020-300207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,16]]},"references-count":60,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,4,27]]},"published-print":{"date-parts":[[2021,5]]}},"alternative-id":["10.1136\/ebmental-2020-300207"],"URL":"https:\/\/doi.org\/10.1136\/ebmental-2020-300207","relation":{},"ISSN":["1362-0347","1468-960X"],"issn-type":[{"value":"1362-0347","type":"print"},{"value":"1468-960X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,16]]}}}